Evaluate sirolimus. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy3

Chyle Kidney Antilymphocyte Serum

Organisms2

Citrus paradisi Mucorales

Diseases15

Lymphangioleiomyomatosis Angiomyolipoma Lymphangiomyoma Coronary Restenosis Thrombotic Microangiopathies Polycystic Kidney, Autosomal Dominant Tuberous Sclerosis Oral Ulcer Renal Insufficiency Perivascular Epithelioid Cell Neoplasms Biliary Fistula Oligomenorrhea Postoperative Complications Graft Occlusion, Vascular Proteinuria

Chemicals and Drugs26

Sirolimus Immunosuppressive Agents Tacrolimus Cyclosporine Mycophenolic Acid Calcineurin TOR Serine-Threonine Kinases Polyenes Creatinine Cardiovascular Agents Drug Implants Antibiotics, Antineoplastic Tubulin Modulators Oxaloacetic Acid Coated Materials, Biocompatible Azathioprine Acetic Anhydrides Antilymphocyte Serum Ribosomal Protein S6 Kinases, 70-kDa Paclitaxel Adrenal Cortex Hormones Ketoconazole Respiratory System Agents Steroids Cytochrome P-450 CYP3A Benzenesulfonates

Analytical, Diagnostic and Therapeutic Techniques and Equipment24

Kidney Transplantation Drug Substitution Injections, Intraocular Drug Therapy, Combination Treatment Outcome Liver Transplantation Transplantation, Homologous Drug-Eluting Stents Drug Monitoring Islets of Langerhans Transplantation Glomerular Filtration Rate Transplantation Fluorescence Polarization Immunoassay Stents Immunosuppression Heart Transplantation Follow-Up Studies Retrospective Studies Kidney Function Tests Biopsy Transplantation Conditioning Prospective Studies Absorbable Implants Coronary Angiography

Phenomena and Processes6

Graft Rejection Graft Survival Time Factors Glomerular Filtration Rate Drug Interactions Dose-Response Relationship, Drug

Technology, Industry, Agriculture1

Coated Materials, Biocompatible

Named Groups2

Unrelated Donors Living Donors

Health Care7

Drug Substitution Treatment Outcome Follow-Up Studies Retrospective Studies Clinical Audit Prospective Studies Intention to Treat Analysis

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Technology, Industry, Agriculture Named Groups Health Care

Sirolimus Immunosuppressive Agents Tacrolimus Kidney Transplantation Cyclosporine Mycophenolic Acid Calcineurin Graft Rejection Drug Substitution Lymphangioleiomyomatosis Angiomyolipoma TOR Serine-Threonine Kinases Graft Survival Lymphangiomyoma Injections, Intraocular Coronary Restenosis Drug Therapy, Combination Treatment Outcome Chyle Liver Transplantation Polyenes Transplantation, Homologous Drug-Eluting Stents Creatinine Kidney Cardiovascular Agents Time Factors Drug Monitoring Islets of Langerhans Transplantation Drug Implants Glomerular Filtration Rate Transplantation Fluorescence Polarization Immunoassay Antibiotics, Antineoplastic Stents Immunosuppression Thrombotic Microangiopathies Tubulin Modulators Oxaloacetic Acid Coated Materials, Biocompatible Citrus paradisi Polycystic Kidney, Autosomal Dominant Azathioprine Acetic Anhydrides Heart Transplantation Follow-Up Studies Drug Interactions Unrelated Donors Retrospective Studies Antilymphocyte Serum Tuberous Sclerosis Oral Ulcer Renal Insufficiency Kidney Function Tests Perivascular Epithelioid Cell Neoplasms Ribosomal Protein S6 Kinases, 70-kDa Paclitaxel Biliary Fistula Biopsy Clinical Audit Adrenal Cortex Hormones Ketoconazole Oligomenorrhea Transplantation Conditioning Respiratory System Agents Mucorales Prospective Studies Steroids Postoperative Complications Absorbable Implants Cytochrome P-450 CYP3A Living Donors Benzenesulfonates Dose-Response Relationship, Drug Intention to Treat Analysis Graft Occlusion, Vascular Coronary Angiography Proteinuria

No FAQ available that match "evaluate sirolimus"